Global Intravenous (IV) Solution Market is Expected to Reach USD 11,511.2 million by 2022

“Intravenous (IV) Solution Market”
Market Research Future published a cooked research report on ” Intravenous (IV) Solution Market Research Report – Global Forecast to 2022″ – Market Analysis, Scope, Stake, Progress, Trends

Global Intravenous (IV) Solution Market Information, by Type (Total Parenteral Solution, Peripheral Parenteral Solution), by Nutritional Content (Amino Acid Solution, Carbohydrates, Vitamins & Minerals, Parenteral Lipid Emulsion and Others), by End User (Hospitals & Clinics, Ambulatory and Homecare) – Forecast to 2022

The Global electrochemical biosensors market, is projected to grow at a CAGR of 9.7% and is expected to reach USD 23707.2 million by 2022. Globally North America accounted for the largest market share in 2016.

Intravenous (IV) Solutions are intended to be administered into the patients which are deficient in nutrients or at the time of serious dehydration. These solutions are given to the patients whose fluid volume or body nutrients falls. Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for intravenous solutions is growing swiftly. 

Get a sample report at https://www.marketresearchfuture.com/sample_request/1235 .

The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. 

Intended Audience

  • Intravenous (IV) Solution Manufacturer
  • Intravenous (IV) Solution Vendors
  • Pharmaceutical & Biotechnology Companies
  • Market Research and Consulting Service Providers 

Key Findings

  • The global Intravenous (IV) Solution market and is expected to reach USD 11,511.2 million by 2022
  • By type, Total Parenteral Nutrition (TPN) holds the largest market share of global Intravenous (IV) Solution market and is expected to reach USD 4,940.0 million in 2016
  • By nutritional content, amino acid solution holds the largest market share of global Intravenous (IV) Solution market is expected to reach USD 2,385.0 million in 2016 

Key Players for Global Intravenous (IV) Solution Market:

  • ICU Medical, Inc. (U.S.)
  • B. Braun Melsungen AG (Germany)
  • Fresenius Kabi AG (Germany)
  • Baxter (U.S.)
  • Amanta Healthcare (India)
  • Terumo Medical Corporation (Tokyo)
  • Grifols S.A. (Spain)

Segments:

Global Intravenous (IV) Solution Market has been segmented on the basis of type which comprises of total parenteral solution, peripheral parenteral solution. On the basis of nutritional content the market is segmented into amino acid solution, carbohydrates, vitamins & minerals, parenteral lipid emulsion and others. On the basis of end user the market is segmented into hospitals & clinics, ambulatory and home care.

Browse Complete Report at https://www.marketresearchfuture.com/reports/intravenous-solution-market .

Regional Analysis of Global Intravenous (IV) Solution Market: 

The global market for Intravenous (IV) Solution is growing rapidly. The market for Intravenous (IV) Solution is growing with the CAGR of 7.69% during the forecast period from 2016-2022. North America accounts for the largest market share in 2015 and is expected to reach USD 4,276.5 million in 2016. This growth is attributed to the factors such as high IV consumption number, high prevalence of chronic diseases. 

Asia-Pacific region is the fastest growing market for real time health monitoring devices, which is expected to grow at a CAGR of 8.34% during the forecast period from 2016 to 2022 is due to the emergence of high-quality and better healthcare infrastructure and institutions in this region.                      

The report for Global Intravenous (IV) Solution Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

 

Request for Discount at https://www.marketresearchfuture.com/check-discount/1235

Table of Content

1 Report Prologue    12

2    Introduction    16

2.1    Scope of Study    16

2.2    Research Objective    16

2.3    Assumptions & Limitations    16

2.3.1    Assumptions    16

2.3.2    Limitations    16

2.4    Market Structure    17

3    Research Methodology    18

3.1    Primary Research    19

3.2    Secondary Research    19

4    Market Dynamics    20

4.1    Introduction    20

4.2    Drivers    21

4.2.1    Increasing Prevalence of the Chronic Diseases    21

4.2.2    Rise of Cholera    21

4.2.3    Growing acceptance of vitamin C intravenous for Colorectal Cancer    22

4.3    Restraints    22

4.3.1    Presence of Stringent Government Regulations    22

4.4    Opportunities    22

4.4.1    Rising continuous demand of IV solutions in U.S.    23

4.5    Challenge    23

4.5.1    Increasing Vitamin C Intravenous Therapy Prices    23

4.6    Mega Trends    24

4.7    Macroeconomic Indicators    24

5    Market Factor Analysis    26

5.1    Porters five forces analysis    26

5.1.1    Introduction    26

5.1.2    Bargaining Power of Suppliers    27

5.1.3    Bargaining Power Of Buyers    27

5.1.4    Threat of Substitutes    27

5.1.5    Rivalry    28

5.1.6    Threat of New Entrants    28

5.2    Value chain Analysis    28

5.2.1    Introduction    28

5.2.2    Inputs    28

5.2.3    Research & Development    29

5.2.4    Development Stage    29

5.2.5    Manufacturing process of IV solutions    29

5.2.6    Marketing And Distribution    29

5.3    Demand Supply Gap Analysis    30

5.4    Price factor analysis    31

5.5    Investment Feasibility Analysis    32

6    Global IV Solution Market, By Types    33

6.1    Introduction    33

6.2    Peripheral Parenteral Nutrition    34

6.3    Total Parenteral Nutrition    35

7    Global IV Solution Market, By Nutritional Content    37

7.1    Introduction    37

7.2    Amino Acid Solution    38

7.3    Carbohydrates    39

7.4    Vitamins & minerals    40

7.5    Parenteral lipid emulsion    40

7.6    Other Solutions    41

8    Global IV Solution Market, By End Users    42

8.1    Introduction    42

8.2    Hospital & Clinics    43

8.3    Ambulatory    44

8.4    Home Care    45

9    Global IV Solution Market, By Regions    46

9.1    Introduction    46

9.2    North America    48

9.2.1    US         51

9.2.2    Canada    52

9.3    Europe    54

9.3.1    Germany    57

9.3.2    France    58

9.3.3    Italy    60

9.3.4    UK    61

9.3.5    Spain    63

9.3.6    Rest of Europe    65

9.4    Asia Pacific    67

9.4.1    Japan    70

9.4.2    China    71

9.4.3    India    73

9.4.4    Republic of Korea    74

9.4.5    Australia    76

9.4.6    Rest of Asia Pacific    78

9.5    Middle East & Africa    80

9.5.1    UAE    83

9.5.2    Saudi Arabia    85

9.5.3    Egypt    86

9.5.4    Rest of Middle East & Africa    88

10    Company Share Analysis    90

11    Company Profiles    92

11.1    Baxter    92

11.1.1    Company Overview    92

11.1.2    Product/Business Segment Overview    92

11.1.3    Financial Overview    93

11.1.4    Key Development    95

11.1.5    SWOT Analysis    95

11.2    Fresenius Kabi AG    96

11.2.1    Company Overview    96

11.2.2    Product/Business Segment Overview    96

11.2.3    Financial Overview    97

11.2.4    Key Development    98

11.2.5    SWOT Analysis    99

11.3    Braun Melsungen AG    100

11.3.1    Overview    100

11.3.2    Product/Business Segment Overview    100

11.3.3    Financial Updates    101

11.3.4    Key Development    102

11.3.5    SWOT Analysis    104

11.4    ICU Medical, Inc.    105

11.4.1    Company overview    105

11.4.2    Product Overview    105

11.4.3    Financials    106

11.4.4    Key Developments    107

11.4.5    SWOT Analysis    108

11.5    Grifols S.A    109

11.5.1    Company Overview    109

11.5.2    Product Overview    109

11.5.3    Financial Overview    110

11.5.4    Key Development    111

11.5.5    SWOT Analysis    112

11.6    Terumo Medical Corporation    113

11.6.1    Company Overview    113

11.6.2    Product Overview    113

11.6.3    Financial Overview    114

11.6.4    Key Developments    115

11.6.5    SWOT Analysis    116

11.7    Amanta Healthcare    117

11.7.1    Company Overview    117

11.7.2    Product Overview    117

11.7.3    Financial Overview    118

12    MRFR Conclusion    119

12.1    Key Findings    119

12.1.1    From CEO’s View Point    119

12.1.2    Unmet Needs    119

12.2    Key companies to watch    119

13    APPENDIX    120

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/intravenous-solution-market